The mortality rate from malignant neoplasms in Japan is projected to increase steadily from 308.4 deaths to 316.5 deaths per hundred thousand persons between 2024 and 2028. This translates to an average annual growth rate of approximately 0.8% over these years. For context, in 2023, the mortality rate was lower than the projected figures, demonstrating an upward trend.

Future trends to watch for include:

Increased aging population in Japan, potentially leading to higher cancer-related mortality rates.
Advancements in medical technology could mitigate these numbers by improving early detection and treatment effectiveness.
The impact of lifestyle changes and preventive measures as part of public health strategies.